Literature DB >> 26016607

Inhibition of imiquimod-induced psoriasis-like dermatitis in mice by herbal extracts from some Indian medicinal plants.

Neha Arora1, Kavita Shah2, Shashi Pandey-Rai3.   

Abstract

Psoriasis is a chronic autoimmune human skin disorder that is characterized by excessive proliferation of keratinocytes, scaly plaques, severe inflammation and erythema. The pathophysiology of psoriasis involves interplay between epidermal keratinocytes, T lymphocytes, leukocytes and vascular endothelium. Increased leukocyte recruitment and elevated levels of cytokines, growth factors and genetic factors like interleukin (IL)-1β, IL-6, IL-17, IL-22, IL-23, tumour necrosis factor (TNF)-α, interferon (IFN)-γ, transforming growth factor (TGF)-β, toll-like receptor (TLR)-2, signal transducer and activator of transcription (STAT-3), 15-lipoxygenase (LOX)-2, coiled-coil alpha-helical rod protein 1 (CCHCR1), steroidogenic acute regulatory protein (StAR) and vitamin D receptor (VDR) are the most critical factors governing the exacerbation of psoriasis. In the present study, an attempt was made to elucidate the preventive role of herbal extracts of four dermo-protective Ayurvedic plants, Tinospora cordifolia (TC), Curcuma longa (CL), Celastrus paniculatus (CP) and Aloe vera (AV), against psoriasis-like dermatitis. Parkes (P) strain mice were initially induced with psoriasis-like dermatitis using topical application of imiquimod (IMQ, 5 %), followed by subsequent treatment with the herbal extracts to examine their curative effect on the psoriasis-like dermatitis-induced mice. The extracts were orally/topically administered to mice according to their ED/LD50 doses. Phenotypical observations, histological examinations, and semi-quantitative reverse transcription PCR (RT-PCR) analyses of the skin and blood samples of the control, IMQ-treated and herbal extract-treated psoriasis-like dermatitis-induced mice lead to the conclusion that the combination extract from all the plants was instrumental in downregulating the overexpressed cytokines, which was followed by the CL extract. Moreover, lesser yet positive response was evident from CP and TC extracts. The results suggest that these plants can prove to have tremendous preventive potential against the disease and can open the way to new therapeutic strategies for psoriasis treatment.

Entities:  

Keywords:  Ayurvedic plants; Cytokines; Histopathology; Interleukins; Psoriasis-like dermatitis; Semi-quantitative RT-PCR

Mesh:

Substances:

Year:  2015        PMID: 26016607     DOI: 10.1007/s00709-015-0829-y

Source DB:  PubMed          Journal:  Protoplasma        ISSN: 0033-183X            Impact factor:   3.356


  63 in total

Review 1.  Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities.

Authors:  Brian J Nickoloff; Frank O Nestle
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

Review 2.  Angiogenesis drives psoriasis pathogenesis.

Authors:  Regina Heidenreich; Martin Röcken; Kamran Ghoreschi
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

3.  Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model.

Authors:  Shigetoshi Sano; Keith Syson Chan; Steve Carbajal; John Clifford; Mary Peavey; Kaoru Kiguchi; Satoshi Itami; Brian J Nickoloff; John DiGiovanni
Journal:  Nat Med       Date:  2004-12-12       Impact factor: 53.440

4.  Production of IL-6 by keratinocytes. Implications for epidermal inflammation and immunity.

Authors:  T S Kupper; K Min; P Sehgal; H Mizutani; N Birchall; A Ray; L May
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

5.  Immunomodulating agents of plant origin. I: Preliminary screening.

Authors:  C K Atal; M L Sharma; A Kaul; A Khajuria
Journal:  J Ethnopharmacol       Date:  1986-11       Impact factor: 4.360

6.  Toll-like receptor (TLR) 2 is upregulated on peripheral blood monocytes of patients with psoriatic arthritis: a role for a gram-positive inflammatory trigger?

Authors:  Solange Carrasco; Fabricio S Neves; Marcela H Fonseca; Célio R Gonçalves; Carla G S Saad; Percival D Sampaio-Barros; Cláudia Goldenstein-Schainberg
Journal:  Clin Exp Rheumatol       Date:  2011-12-22       Impact factor: 4.473

7.  In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.

Authors:  Gamze Piskin; Regien M R Sylva-Steenland; Jan D Bos; Marcel B M Teunissen
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

8.  Upregulation of 8-lipoxygenase in the dermatitis of IkappaB-alpha-deficient mice.

Authors:  Claus Schneider; W David Strayhorn; Dana M Brantley; Lillian B Nanney; Fiona E Yull; Alan R Brash
Journal:  J Invest Dermatol       Date:  2004-03       Impact factor: 8.551

9.  The identification of hydroxy fatty acids in psoriatic skin.

Authors:  R D Camp; A I Mallet; P M Woollard; S D Brain; A K Black; M W Greaves
Journal:  Prostaglandins       Date:  1983-09

10.  Psoriasis induced by topical imiquimod.

Authors:  Jason K Wu; Greg Siller; Geoff Strutton
Journal:  Australas J Dermatol       Date:  2004-02       Impact factor: 2.875

View more
  6 in total

1.  Methotrexate-Loaded Nanostructured Lipid Carrier Gel Alleviates Imiquimod-Induced Psoriasis by Moderating Inflammation: Formulation, Optimization, Characterization, In-Vitro and In-Vivo Studies.

Authors:  Yogeeta O Agrawal; Umesh B Mahajan; Hitendra S Mahajan; Shreesh Ojha
Journal:  Int J Nanomedicine       Date:  2020-07-07

2.  B1 and B2 kinin receptor blockade improves psoriasis-like disease.

Authors:  Bruna da Silva Soley; Leonardo Martins Silva; Daniel Augusto Gasparin Bueno Mendes; André Báfica; João Bosco Pesquero; Michael Bader; Deborah A Witherden; Wendy L Havran; João B Calixto; Michel Fleith Otuki; Daniela Almeida Cabrini
Journal:  Br J Pharmacol       Date:  2020-05-30       Impact factor: 8.739

3.  In Vitro Effects of Some Botanicals with Anti-Inflammatory and Antitoxic Activity.

Authors:  Gianandrea Guidetti; Alessandro Di Cerbo; Angela Giovazzino; Valentina Rubino; Anna Teresa Palatucci; Sara Centenaro; Elena Fraccaroli; Laura Cortese; Maria Grazia Bonomo; Giuseppina Ruggiero; Sergio Canello; Giuseppe Terrazzano
Journal:  J Immunol Res       Date:  2016-08-15       Impact factor: 4.818

4.  Douchi (fermented Glycine max Merr.) alleviates atopic dermatitis-like skin lesions in NC/Nga mice by regulation of PKC and IL-4.

Authors:  A-Ram Jung; Sang-Hyun Ahn; In-Sik Park; Sun-Young Park; Seung-Il Jeong; Jin-Hong Cheon; Kibong Kim
Journal:  BMC Complement Altern Med       Date:  2016-10-24       Impact factor: 3.659

5.  Variances in the mRNA expression profile of TGF-β1-3 isoforms and its TGF-βRI-III receptors during cyclosporin a treatment of psoriatic patients.

Authors:  Anna Michalska-Bańkowska; Dominika Wcisło-Dziadecka; Beniamin Grabarek; Ligia Brzezińska-Wcisło; Urszula Mazurek; Natalia Salwowska; Mirosław Bańkowski
Journal:  Postepy Dermatol Alergol       Date:  2018-07-19       Impact factor: 1.837

6.  Antipsoriatic Effects of Wannachawee Recipe on Imiquimod-Induced Psoriasis-Like Dermatitis in BALB/c Mice.

Authors:  Mingkwan Na Takuathung; Ariyaphong Wongnoppavich; Ampai Panthong; Parirat Khonsung; Natthakarn Chiranthanut; Noppamas Soonthornchareonnon; Seewaboon Sireeratawong
Journal:  Evid Based Complement Alternat Med       Date:  2018-01-24       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.